|
Delayed
Bombay S.E.
07:26:30 24/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,894.20 INR | +3.69% |
|
+11.85% | +57.67% |
| 08-14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 08-12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAPLIN POINT LABORATORIES LIMITED | Generic Pharmaceuticals | +3.69% | +11.85% | +57.67% | +28.33% | +226.22% | 2.21B |  |  | |
Select your edition
All financial news and data tailored to specific country editions
